E
Overview
Eupry provides temperature and humidity monitoring solutions for regulated industries such as pharmaceuticals, biotechnology, and healthcare logistics. It combines Wi-Fi data loggers (hardware) with a SaaS software platform to continuously track environmental conditions, send real-time alerts for deviations, and maintain an auditable regulatory trail (GxP and FDA 21 CFR Part 11). The system integrates hardware and software with calibration and mapping services under one subscription. Its goal is to help customers stay compliant, protect sensitive products, and reduce time and resources spent on monitoring and audits.
Work here?Claim your company
Simplify's take
What believers are saying
- April 2026 closed a $24 million Series A from Chr. Augustinus Fabrikker and EIFO.
- June 2026 FDA analysis showed monitoring failures in nearly one-third of pharma warning letters.
- Eupry's 2026 webinars and articles signal strong inbound demand from regulated operators and auditors.
What critics are saying
- Incumbents Testo, Vaisala, Sensitech, and Honeywell squeeze Eupry's hardware margins by 2027.
- Platform breadth invites execution failure if product quality slips across monitoring, mapping, and calibration.
- If U.S. expansion stalls after the 2026 Series A, Eupry remains a Nordic niche vendor.
What makes Eupry unique
- Eupry combines monitoring, mapping, validation, and calibration in one GxP platform.
- October 2026 launched dual compliance and continuous aircraft mapping for pharma air freight.
- Partnerships with QbD Group, Blue Mountain, and Aerotak widen distribution and integrations.
Help us improve and share your feedback! Did you find this helpful?